Screener
Agios Pharmaceuticals AGIO Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands, except share and per share data) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Product revenue, net | $44,745 | $12,455 | $65,491 | $21,181 |
| Total revenue | 44,745 | 12,455 | 65,491 | 21,181 |
| Operating expenses: | ||||
| Cost of sales | $2,996 | $1,702 | $4,315 | $2,787 |
| Research and development | 100,754 | 91,940 | 181,902 | 164,683 |
| Selling, general and administrative | 51,547 | 45,869 | 99,851 | 87,396 |
| Total operating expenses | 155,297 | 139,511 | 286,068 | 254,866 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's total revenue?
- Agios Pharmaceuticals (AGIO) reported total revenue of $44.75M in Q2 2026.
- How has Agios Pharmaceuticals's total revenue changed year-over-year?
- Agios Pharmaceuticals's total revenue increased by 259.3% year-over-year, from $12.46M to $44.75M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Agios Pharmaceuticals's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude